Rybelsus 14 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FW83T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,146
Award facts
- Contract value 100% obligated
- $14,146.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,146.18 delivery order to AmerisourceBergen Drug Corp for Rybelsus 14 mg tablets (30-count units) on May 6, 2025, with an ultimate completion date of May 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, maintains an extensive portfolio of contract awards with the Defense Logistics Agency covering diverse therapeutic domains including diabetes medications, neurological treatments, and specialized medical supplies. The company's demonstrated capability to fulfill federal procurement requirements through open competition, coupled with its comprehensive pharmaceutical supply network, positions it to serve military healthcare systems and other government agencies. This delivery order for Rybelsus, a medication used in diabetes treatment, reflects the company's ongoing role in supporting the Defense Health Agency and broader military medical supply operations.
Quick answers
Who was awarded contract SPE2DB25FW83T?
SPE2DB25FW83T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 6, 2025.
How much is contract SPE2DB25FW83T worth?
The government has obligated $14,146 on SPE2DB25FW83T.
Is contract SPE2DB25FW83T an order under another contract?
Yes. SPE2DB25FW83T is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FW83T competed?
The extent of competition for SPE2DB25FW83T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award